Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Novartis Pharmaceuticals
Novartis Pharmaceuticals
Study Director - Steven Young, M.D.
Somerset Hematology Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California at Los Angeles
Los Angeles, California, United States
- Stanford University Medical Center Division of Hematology
Stanford, California, United States
- H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, United States
- Emory University School of Medicine/winship Cancer Institute Dept. of Winship Cancer Inst.
Atlanta, Georgia, United States
- Georgia Regents University Medcollege of Ga Cancer Ctr 2
Augusta, Georgia, United States
- Hematology/oncology of the North Shore Orchard Healthcare Res. Inc.
Skokie, Illinois, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Somerset Hematology Oncology Associates Somerset Hema Oncol Assoc (2)
Somerset, New Jersey, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Duke University Medical Center Dept. of Dumc (4)
Durham, North Carolina, United States
- Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt Umc
Nashville, Tennessee, United States
- Md Anderson Cancer Center/university of Texas Md Anderson Cc
Houston, Texas, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2010
- Primary completion
- 28 Feb 2014
- Completion
- 28 Feb 2014
- Last update posted
- 21 Dec 2017
- Registered enrollment
- 55
- Registry id
- NCT01083602
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.